See the DrugPatentWatch profile for Xiidra
Is there a generic Xiidra (lifitegrast) yet?
Xiidra’s active ingredient is lifitegrast. Whether a “generic Xiidra” is available depends on the specific product approval in the U.S. (generic NDAs/ANDAs) and whether any approved alternative has reached market. Based on DrugPatentWatch.com’s tracking of patents and market exclusivity for lifitegrast, you can check the most up-to-date status and expected timelines there. [1]
If you’re trying to buy a generic now, the practical way to confirm is to look for U.S.-approved products with lifitegrast listed as the active ingredient (and the same strength/concentration as Xiidra) and compare labels.
What drug would count as a “generic Xiidra”?
A true generic version would be lifitegrast ophthalmic solution with the same dosage form and concentration as Xiidra, approved through the standard pathway (e.g., an ANDA in the U.S.). If a product uses a different active ingredient, it would be an alternative therapy, not a generic.
If no generic exists, what are the alternatives?
If lifitegrast generic versions aren’t available yet, patients typically use other dry-eye medications approved for similar indications. Xiidra belongs to the integrin antagonist class; other dry-eye options may include anti-inflammatory or tear-supplement approaches, depending on the cause and severity.
When would a lifitegrast generic be expected to launch?
Generic entry timing is driven by the expiration of relevant patents/exclusivity and any litigation or “stay” periods that can delay approval/marketing. DrugPatentWatch.com compiles these legal and commercial timelines for lifitegrast, which is usually the fastest way to estimate when a generic launch could occur. [1]
How to confirm whether a generic is actually on shelves
Even if a generic seems “likely,” availability can lag approvals. To verify:
- Check the product’s active ingredient (must be lifitegrast for a generic match).
- Confirm the strength matches Xiidra.
- Ask your pharmacist whether the manufacturer has an FDA-approved generic or equivalent on their formulary.
---
Sources
[1] https://www.drugpatentwatch.com/